BR112012009162B8 - composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos - Google Patents

composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos

Info

Publication number
BR112012009162B8
BR112012009162B8 BR112012009162A BR112012009162A BR112012009162B8 BR 112012009162 B8 BR112012009162 B8 BR 112012009162B8 BR 112012009162 A BR112012009162 A BR 112012009162A BR 112012009162 A BR112012009162 A BR 112012009162A BR 112012009162 B8 BR112012009162 B8 BR 112012009162B8
Authority
BR
Brazil
Prior art keywords
dimethyl
ammonium
ethyl
preparation process
butanoate compound
Prior art date
Application number
BR112012009162A
Other languages
English (en)
Other versions
BR112012009162B1 (pt
BR112012009162A2 (pt
Inventor
Liepins Edgars
Loza Einars
Kalvins Ivars
Kuka Janis
Dambrova Maija
Pugovics Osvalds
Vilskersts Reinis
Grinberga Solviega
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of BR112012009162A2 publication Critical patent/BR112012009162A2/pt
Publication of BR112012009162B1 publication Critical patent/BR112012009162B1/pt
Publication of BR112012009162B8 publication Critical patent/BR112012009162B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos novo composto 4-[etil(dimetil)amônio] butanoato, método de preparação do mesmo e uso no tratamento de doença cardiovascular.
BR112012009162A 2009-10-22 2010-10-22 composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos BR112012009162B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LVP-09-181 2009-10-22
LVP-09-181A LV14345B (lv) 2009-10-22 2009-10-22 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
PCT/EP2010/065924 WO2011048201A1 (en) 2009-10-22 2010-10-22 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Publications (3)

Publication Number Publication Date
BR112012009162A2 BR112012009162A2 (pt) 2020-08-18
BR112012009162B1 BR112012009162B1 (pt) 2021-02-02
BR112012009162B8 true BR112012009162B8 (pt) 2021-07-27

Family

ID=43530044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012009162A BR112012009162B8 (pt) 2009-10-22 2010-10-22 composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos

Country Status (33)

Country Link
US (2) US9278907B2 (pt)
EP (1) EP2491005B1 (pt)
JP (1) JP5552169B2 (pt)
KR (1) KR101355417B1 (pt)
CN (1) CN102666476B (pt)
AR (1) AR081514A1 (pt)
AU (1) AU2010309756B2 (pt)
BR (1) BR112012009162B8 (pt)
CA (1) CA2781499C (pt)
CL (1) CL2012001010A1 (pt)
CO (1) CO6531459A2 (pt)
CU (1) CU20120065A7 (pt)
DK (1) DK2491005T3 (pt)
EA (1) EA020303B1 (pt)
ES (1) ES2508117T3 (pt)
GE (1) GEP20146123B (pt)
HK (1) HK1169824A1 (pt)
HR (1) HRP20140964T1 (pt)
IL (1) IL219217A0 (pt)
LV (1) LV14345B (pt)
ME (1) ME01917B (pt)
MX (1) MX2012004630A (pt)
NZ (1) NZ599521A (pt)
PE (1) PE20121473A1 (pt)
PL (1) PL2491005T3 (pt)
PT (1) PT2491005E (pt)
RS (1) RS53620B1 (pt)
SI (1) SI2491005T1 (pt)
SM (1) SMT201400176B (pt)
TN (1) TN2012000174A1 (pt)
UA (1) UA107201C2 (pt)
WO (1) WO2011048201A1 (pt)
ZA (1) ZA201202916B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565150B2 (en) * 2009-03-11 2013-10-22 At&T Mobility Ii Llc Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment
PE20140777A1 (es) 2011-04-27 2014-07-20 Grindeks Jsc Metodo de obtencion de una composicion farmaceutica de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio para el tratamiento de enfermedades cardiovasculares
DE102012109911A1 (de) 2011-10-19 2013-04-25 Electronics And Telecommunications Research Institute Energy harvesting device using electromagnetic interference signal and sensor system including the same
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه
CN107879944B (zh) * 2017-10-30 2020-05-22 杭州海尔希畜牧科技有限公司 一种制备丁基甜菜碱的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (pt) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4933103A (en) * 1987-03-23 1990-06-12 Kao Corporation Bleaching composition
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JPH0291049A (ja) * 1988-09-21 1990-03-30 Lonza Ag ｒ―ブチロベタインの製造方法
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
JP2000239239A (ja) * 1999-02-22 2000-09-05 Kankyo Meneki Gijutsu Kenkyusho:Kk クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN101538214A (zh) * 2009-04-24 2009-09-23 潍坊祥维斯化学品有限公司 生产γ-丁基甜菜碱及其盐酸盐的方法
BR112013027075A2 (pt) * 2011-04-27 2016-12-27 Grindeks Jsc 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares

Also Published As

Publication number Publication date
PE20121473A1 (es) 2012-11-18
SMT201400176B (it) 2015-01-15
EA201200514A1 (ru) 2012-09-28
CA2781499A1 (en) 2011-04-28
LV14345B (lv) 2011-07-20
WO2011048201A1 (en) 2011-04-28
NZ599521A (en) 2013-11-29
AR081514A1 (es) 2012-10-03
JP5552169B2 (ja) 2014-07-16
ZA201202916B (en) 2013-05-29
LV14345A (lv) 2011-05-20
IL219217A0 (en) 2012-06-28
EP2491005A1 (en) 2012-08-29
US20160137589A1 (en) 2016-05-19
JP2013508342A (ja) 2013-03-07
RS53620B1 (en) 2015-04-30
EP2491005B1 (en) 2014-07-23
KR101355417B1 (ko) 2014-01-27
US9278907B2 (en) 2016-03-08
UA107201C2 (uk) 2014-12-10
AU2010309756B2 (en) 2013-10-17
PL2491005T3 (pl) 2015-03-31
EA020303B1 (ru) 2014-10-30
DK2491005T3 (da) 2014-10-27
BR112012009162B1 (pt) 2021-02-02
CA2781499C (en) 2015-03-24
AU2010309756A1 (en) 2012-05-17
HK1169824A1 (en) 2013-02-08
US20120220656A1 (en) 2012-08-30
GEP20146123B (en) 2014-07-25
MX2012004630A (es) 2013-07-29
BR112012009162A2 (pt) 2020-08-18
CU24114B1 (pt) 2015-08-27
CN102666476A (zh) 2012-09-12
ME01917B (me) 2015-05-20
HRP20140964T1 (hr) 2014-12-05
SI2491005T1 (sl) 2014-12-31
CN102666476B (zh) 2014-07-09
CU20120065A7 (es) 2012-06-29
CO6531459A2 (es) 2012-09-28
KR20120101634A (ko) 2012-09-14
CL2012001010A1 (es) 2012-08-31
US9573882B2 (en) 2017-02-21
ES2508117T3 (es) 2014-10-16
TN2012000174A1 (en) 2013-12-12
PT2491005E (pt) 2014-10-29

Similar Documents

Publication Publication Date Title
BR112012009162B8 (pt) composto 4-[etil(dimetil)amônio] butanoato, seu processo preparação e usos
BRPI0918972A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso
BRPI0915728A2 (pt) composição enzimática, processo para preparar a composição, uso da composição enzimática, e, composição detergente.
WO2010094009A3 (en) Methods and compositions for the treatment of ras associated disorders
BRPI0905663A2 (pt) "emulsão estável, processo de preparação da emulsão estável e uso emulsão"
BRPI0810632A2 (pt) Derivados de piridopirazina, processo de fabricação e usos dos mesmos
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
BRPI0920026A2 (pt) método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.
BRPI0914682B8 (pt) compostos de heteroarila e composições compreendendo os referidos compostos
BRPI1007545A2 (pt) composição aquosa, e, processo para aperfeiçoar tratamento de cabelo
BR112013007229A2 (pt) ''composição,mistura e processo''.
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0606132A2 (pt) formas cristalinas de docetaxel e processos para seu preparo
BRPI0819047A2 (pt) "composição, seu processo de preparação e seus usos"
BRPI1006974A2 (pt) "uso de absorvedores de uv, e, composição cosmética."
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
BRPI1010550A2 (pt) formas de dosagem, e, processo para a produção de preparações para formas de dosagem de substãncias ativas fracamente solúveis e, água.
BRPI0710405B8 (pt) comprimido de racecadotril, processo de preparação de um comprimido de racecadotril e uso de racecadotril
EE200800063A (et) N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine
BR112012000423A2 (pt) catalizador enzimático heterogêneo, processo de preparação, e, utilização do mesmo.
BRPI0920892A2 (pt) Composição de bebida e processo de redução de degradação de monatina.
ITMI20060082A1 (it) Processo per la preparazione di biodiesel
BRPI1013051A2 (pt) composição imunogênica, uso de uma composição imunogênica, processo para fazer uma composição imunogênica, e, kit.
BRPI0907679A2 (pt) Composto, processo de preparação de um composto e uso do composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO